Get the Stockscreener App
64.72
9.01%
-6.41
Tempus Ai Inc stock is traded at $64.72, with a volume of 6.85M.
It is down -9.01% in the last 24 hours and down -7.50% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$71.13
Open:
$70.89
24h Volume:
6.85M
Relative Volume:
0.92
Market Cap:
$11.75B
Revenue:
$1.36B
Net Income/Loss:
$-302.91M
P/E Ratio:
-37.67
EPS:
-1.7182
Net Cash Flow:
$-219.93M
1W Performance:
-8.76%
1M Performance:
-7.50%
6M Performance:
+18.93%
1Y Performance:
-28.89%
1-Day Range:
$63.79
$72.50
1-Week Range:
$63.60
$72.81
52-Week Range:
$40.77
$97.25
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
64.72 | 11.75B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
310.36 | 50.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
60.87 | 12.04B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
99.16 | 8.00B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.03 | 7.61B | 1.34B | 230.70M | 440.96M | 2.6695 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-21-26 | Initiated | Goldman | Neutral |
| Sep-09-26 | Initiated | UBS | Neutral |
| Sep-08-26 | Initiated | Rothschild & Co Redburn | Neutral |
| Sep-02-26 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-01-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-02-26 | Resumed | Wolfe Research | Peer Perform |
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
What Does Tempus AI Do With Genomic and Clinical Data? - Kalkine Media
Tempus AI Expands Strategic Collaborations to Drive Future Growth - Zacks Investment Research
Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom? - Zacks Investment Research
A trading plan governed the sale of 10,281 Tempus AI (TEM) shares by its diagnostics CEO at $85 each. - Stock Titan
Tempus AI CEO Lefkofsky sells $16.1m common stock - Investing.com
Tempus AI CAO Ryan Bartolucci sells $529,650 in stock - Investing.com
Tempus AI EVP Andrew Polovin sells 2,951 shares for $221,325 - Investing.com
AI in Clinical Trials Market Set for Transformative Growth Through 2040, Unlocking Opportunities Across Trial Phases, Therapeutic Areas, End Users and Key Global Regions - GlobeNewswire Inc.
Tempus AI CEO-linked entities sell 250,000 shares - Stock Titan
Tempus AI, Inc. (TEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tempus AI’s EVP, chief legal officer, sells $221,325 in stock By Investing.com - Investing.com Canada
Tempus AI chief accounting officer sells $529,650 in stock By Investing.com - Investing.com Nigeria
Tempus AI’s EVP, chief legal officer, sells $221,325 in stock - Investing.com
Tempus AI CEO Eric P. Lefkofsky sells $16.1 million of stock - Investing.com
Tempus AI CEO, data Ryan Fukushima sells $49,000 in stock - Investing.com
Tempus AI’s EVP, chief legal officer, sells $221,325 in stock By Investing.com - Investing.com South Africa
Tempus AI CEO, data Ryan Fukushima sells $49,000 in stock - Investing.com India
Tempus AI (TEM) data chief’s spouse sells 700 shares under plan - Stock Titan
Tempus AI (TEM) CAO sells stock in preset 10b5-1 trade - Stock Titan
Tempus AI (TEM) CEO’s 200,000-share sale was preplanned - Stock Titan
EVP at Tempus AI (TEM) sells shares in preset plan trade - Stock Titan
Tempus AI Stock (TEM) Opinions on Recent Chart Setups and Price Targets - Quiver Quantitative
Tempus AI Stock Price: TEM Stock Chart, Market Cap & News Today - CoinGecko
H.C. Wainwright raises Tempus AI stock price target to $66 By Investing.com - Investing.com Australia
H.C. Wainwright raises Tempus AI stock price target to $66 By Investing.com - Investing.com Australia
Best Artificial Intelligence Stocks To ConsiderSeptember 11th - MarketBeat
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation - 01net
H.C. Wainwright raises Tempus AI stock price target to $66 By Investing.com - Investing.com Nigeria
Tempus AI, Inc. Launches Effort To Build The Largest Multimodal Whole-Genome Dataset To Advance AI-Driven Healthcare Innovation - marketscreener.com
H.C. Wainwright raises Tempus AI stock price target to $66 By Investing.com - Investing.com South Africa
Tempus AI Building Multimodal Whole-Genome Dataset for AI Research - marketscreener.com
Tempus AI plans 100,000 whole genome sequencing dataset - investing.com
Nvidia, Snowflake, Chubb And A Health Care Stock On CNBC’s ‘Final Trades’ - Benzinga
Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
TEM Maintained by HC Wainwright & Co. -- Price Target Raised to $66.00 - GuruFocus
H.C. Wainwright raises Tempus AI stock price target to $66 By Investing.com - Investing.com India
H.C. Wainwright raises Tempus AI stock price target to $66 - investing.com
Top Artificial Intelligence Stocks To ResearchSeptember 10th - MarketBeat
Tracking Cathie Wood: Loading Up on Gene-Editing BEAM、NTLA, Trimming Googl and Tempus AI - Moomoo
Tempus AI wins up to $9.5 million ARPA-H ADVOCATE award for autonomous heart failure agent - Bitget
TEM 8-K FilingsTempus AI, Inc. SEC 8-K - Stock Titan
Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology - 01net
Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology - marketscreener.com
Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology - Business Wire
Top Artificial Intelligence Stocks To Follow NowSeptember 9th - MarketBeat
UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target - Moomoo
Tempus AI (NASDAQ:TEM) Now Covered by Analysts at UBS Group - MarketBeat
Tempus AI (NASDAQ:TEM) Upgraded to Hold at Rothschild & Co Redburn - MarketBeat
Rothschild Redburn initiates Tempus AI stock coverage at Neutral By Investing.com - Investing.com Australia
Tempus AI (NASDAQ:TEM) Coverage Initiated at Roth Capital - MarketBeat
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tempus Ai Inc Stock (TEM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| THOMAS SCHOENHERR | Officer |
Sep 25 '26 |
Proposed Sale |
82.24 |
10,281 |
845,509 |
0 |
| Eric Lefkofsky | Officer |
Sep 22 '26 |
Proposed Sale |
78.03 |
250,000 |
19,507,500 |
0 |
| LEFKOFSKY ERIC P | CEO and Chairman |
Sep 22 '26 |
Sale |
77.47 |
250,000 |
19,366,630 |
100,000 |
| LEFKOFSKY ERIC P | CEO and Chairman |
Sep 17 '26 |
Sale |
80.57 |
200,000 |
16,113,802 |
809,631 |
| RYAN BARTOLUCCI | Officer |
Sep 17 '26 |
Proposed Sale |
69.97 |
9,311 |
651,491 |
0 |
| Eric Lefkofsky | Officer |
Sep 17 '26 |
Proposed Sale |
69.97 |
200,000 |
13,994,000 |
0 |
| Bartolucci Ryan M | Chief Accounting Officer |
Sep 17 '26 |
Sale |
75.00 |
7,062 |
529,650 |
60,804 |
| Polovin Andrew | EVP, Chief Legal Officer |
Sep 17 '26 |
Sale |
75.00 |
2,951 |
221,325 |
135,189 |
| ANDREW POLOVIN | Officer |
Sep 17 '26 |
Proposed Sale |
69.97 |
2,951 |
206,481 |
0 |
| VANESSA KUBO | Officer |
Sep 16 '26 |
Proposed Sale |
68.85 |
700 |
48,195 |
0 |
2.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):